SLC12A9 抗体
(Solute Carrier Family 12 (Potassium/chloride Transporters), Member 9 (SLC12A9))
a putative cation-chloride cotransporter
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SLC12A9 抗体 (AA 126-173) | 人 | 兔 Polyclonal |
|
|
|
| SLC12A9 抗体 (AA 126-173) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| SLC12A9 抗体 (AA 126-173) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| SLC12A9 抗体 (AA 126-173) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| SLC12A9 抗体 (AA 140-154) | 斑马鱼 | 兔 Polyclonal |
|
|
|
| SLC12A9 抗体 | 人 | 兔 Polyclonal |
|
|
|
| SLC12A9 抗体 (AA 126-173) (FITC) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 126-173
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 126-173
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 126-173
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 126-173
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 斑马鱼
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 140-154
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 126-173
Latest Publications for our SLC12A9 抗体
: "Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression." in: The Journal of cell biology, Vol. 153, Issue 7, pp. 1381-90, (2001) (PubMed).
: "PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells." in: Oncogene, Vol. 20, Issue 46, pp. 6794-804, (2001) (PubMed).
: "Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III." in: The Journal of biological chemistry, Vol. 276, Issue 2, pp. 1555-63, (2001) (PubMed).
: "The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 6, Issue 5, pp. 1896-9, (2000) (PubMed).
: "Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition." in: Molecular and cellular biology, Vol. 18, Issue 1, pp. 546-57, (1998) (PubMed).
: "PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells." in: Oncogene, Vol. 20, Issue 46, pp. 6794-804, (2001) (PubMed).
: "Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III." in: The Journal of biological chemistry, Vol. 276, Issue 2, pp. 1555-63, (2001) (PubMed).
: "The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 6, Issue 5, pp. 1896-9, (2000) (PubMed).
: "Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition." in: Molecular and cellular biology, Vol. 18, Issue 1, pp. 546-57, (1998) (PubMed).
Aliases for SLC12A9 抗体
solute carrier family 12 (potassium/chloride transporters), member 9 (Slc12a9) 抗体solute carrier family 12, member 9 (Slc12a9) 抗体
solute carrier family 12 member 9 (SLC12A9) 抗体
solute carrier family 12, member 9 L homeolog (slc12a9.L) 抗体
Ccc6 抗体
CCC6 抗体
CIP1 抗体
Cip1 抗体
cip1 抗体
hCCC6 抗体
WO3.3 抗体
您还需要查找其他产品吗？
You are here:
